172 related articles for article (PubMed ID: 21603209)
1. Preparation and Characterization of Stealth Archaeosomes Based on a Synthetic PEGylated Archaeal Tetraether Lipid.
Barbeau J; Cammas-Marion S; Auvray P; Benvegnu T
J Drug Deliv; 2011; 2011():396068. PubMed ID: 21603209
[TBL] [Abstract][Full Text] [Related]
2. Bipolar tetraether archaeosomes exhibit unusual stability against autoclaving as studied by dynamic light scattering and electron microscopy.
Brown DA; Venegas B; Cooke PH; English V; Chong PL
Chem Phys Lipids; 2009 Jun; 159(2):95-103. PubMed ID: 19477316
[TBL] [Abstract][Full Text] [Related]
3. Polar Lipid Fraction E from
Ayesa U; Chong PL
Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33182284
[TBL] [Abstract][Full Text] [Related]
4. Influence of coenzyme Q10 on tissue distribution of archaeosomes, and pegylated archaeosomes, administered to mice by oral and intravenous routes.
Omri A; Makabi-Panzu B; Agnew BJ; Sprott GD; Patel GB
J Drug Target; 2000; 7(5):383-92. PubMed ID: 10721800
[TBL] [Abstract][Full Text] [Related]
5. New generation of liposomes called archaeosomes based on natural or synthetic archaeal lipids as innovative formulations for drug delivery.
Benvegnu T; Lemiègre L; Cammas-Marion S
Recent Pat Drug Deliv Formul; 2009 Nov; 3(3):206-20. PubMed ID: 19534669
[TBL] [Abstract][Full Text] [Related]
6. Archaeal lipids in oral delivery of therapeutic peptides.
Jacobsen AC; Jensen SM; Fricker G; Brandl M; Treusch AH
Eur J Pharm Sci; 2017 Oct; 108():101-110. PubMed ID: 28108360
[TBL] [Abstract][Full Text] [Related]
7. In vitro characterization of PEGylated phospholipid micelles for improved drug solubilization: effects of PEG chain length and PC incorporation.
Ashok B; Arleth L; Hjelm RP; Rubinstein I; Onyüksel H
J Pharm Sci; 2004 Oct; 93(10):2476-87. PubMed ID: 15349957
[TBL] [Abstract][Full Text] [Related]
8. Erratum: Preparation of Poly(pentafluorophenyl acrylate) Functionalized SiO2 Beads for Protein Purification.
J Vis Exp; 2019 Apr; (146):. PubMed ID: 31038480
[TBL] [Abstract][Full Text] [Related]
9. The potential of archaeosomes as carriers of pDNA into mammalian cells.
Attar A; Ogan A; Yucel S; Turan K
Artif Cells Nanomed Biotechnol; 2016; 44(2):710-6. PubMed ID: 25650647
[TBL] [Abstract][Full Text] [Related]
10. A comparison of the immune responses induced by antigens in three different archaeosome-based vaccine formulations.
Jia Y; Akache B; Deschatelets L; Qian H; Dudani R; Harrison BA; Stark FC; Chandan V; Jamshidi MP; Krishnan L; McCluskie MJ
Int J Pharm; 2019 Apr; 561():187-196. PubMed ID: 30836154
[TBL] [Abstract][Full Text] [Related]
11. Safety and biodistribution of sulfated archaeal glycolipid archaeosomes as vaccine adjuvants.
Akache B; Stark FC; Iqbal U; Chen W; Jia Y; Krishnan L; McCluskie MJ
Hum Vaccin Immunother; 2018 Jul; 14(7):1746-1759. PubMed ID: 29336668
[TBL] [Abstract][Full Text] [Related]
12. Archaeobacterial ether lipid liposomes (archaeosomes) as novel vaccine and drug delivery systems.
Patel GB; Sprott GD
Crit Rev Biotechnol; 1999; 19(4):317-57. PubMed ID: 10723627
[TBL] [Abstract][Full Text] [Related]
13. In vitro evaluation of archaeosome vehicles for transdermal vaccine delivery.
Jia Y; McCluskie MJ; Zhang D; Monette R; Iqbal U; Moreno M; Sauvageau J; Williams D; Deschatelets L; Jakubek ZJ; Krishnan L
J Liposome Res; 2018 Dec; 28(4):305-314. PubMed ID: 28948854
[TBL] [Abstract][Full Text] [Related]
14. Glycosidase-induced fusion of isoprenoid gentiobiosyl lipid membranes at acidic pH.
Sprott GD; Côté JP; Jarrell HC
Glycobiology; 2009 Mar; 19(3):267-76. PubMed ID: 19029107
[TBL] [Abstract][Full Text] [Related]
15. Concentration-Induced J-Aggregate Formation Causes a Biphasic Change in the Release of trans-Combretastatin A4 Disodium Phosphate from Archaeosomes and the Subsequent Cytotoxicity on Mammary Cancer Cells.
Daswani VP; Ayesa U; Venegas B; Chong PL
Mol Pharm; 2015 Oct; 12(10):3724-34. PubMed ID: 26355665
[TBL] [Abstract][Full Text] [Related]
16. Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review.
Hadinoto K; Sundaresan A; Cheow WS
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):427-43. PubMed ID: 23872180
[TBL] [Abstract][Full Text] [Related]
17. Sulfated archaeal glycolipid archaeosomes as a safe and effective vaccine adjuvant for induction of cell-mediated immunity.
McCluskie MJ; Deschatelets L; Krishnan L
Hum Vaccin Immunother; 2017 Dec; 13(12):2772-2779. PubMed ID: 28537465
[TBL] [Abstract][Full Text] [Related]
18. Archaeosomes: New Generation of Liposomes Based on Archaeal Lipids for Drug Delivery and Biomedical Applications.
Santhosh PB; Genova J
ACS Omega; 2023 Jan; 8(1):1-9. PubMed ID: 36643444
[TBL] [Abstract][Full Text] [Related]
19. Vesicular and Planar Membranes of Archaea Lipids: Unusual Physical Properties and Biomedical Applications.
Chong PL; Chang A; Yu A; Mammedova A
Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35886964
[TBL] [Abstract][Full Text] [Related]
20. Assessment of stability of sulphated lactosyl archaeol archaeosomes for use as a vaccine adjuvant.
Jia Y; Chandan V; Akache B; Qian H; Jakubek ZJ; Vinogradov E; Dudani R; Harrison BA; Jamshidi MP; Stark FC; Deschatelets L; Sauvageau J; Williams D; Krishnan L; McCluskie MJ
J Liposome Res; 2021 Sep; 31(3):237-245. PubMed ID: 32583693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
